Burning mouth syndrome and Reflux Disease: relationship and clinical implications Clinical implications of BMS and reflux
Main Article Content
Keywords
Stomatodynia, Glossodynia, Burning mouth syndrome, GERD, Reflux, Gastroesophageal reflux disease
Abstract
Background and aim: An association between reflux and burning mouth syndrome (BMS) has been proposed. Aims of this study were: 1) to investigate the frequency of BMS in a sample of GERD patients; 2) to measure G17, in a sample of BMS patients; 3) to assess the efficacy of different therapeutical schedules for GERD in BMS patients.
Methods: We divided the study in 3 main steps. In step one, we analyzed 500 consecutive GERD patients' type and frequency of extraesophageal manifestations including BMS. In step two, we collected 124 consecutive BMS patients' symptoms and G17. In step three, we evaluate the efficacy of 3 different drugs on BMS.
Results: In step one, 204 patients complained heartburn; 31 globus pharyngeus; 52 chronic cough; 54 pharyngitis; 31 postnasal drip; 56 burning mouth symptoms; 34 noncardiac chest pain; 17 asthma and 21 sleep apnea. In step two, 29 patients had G17 ≤ 1 pg/L; 64 patients between 1 and 3; and 31 patients ≥ 3. In step three, 49 patients reported slight benefit with PPI, 75 no benefit.
61 patients reported slight benefit with sodium alginate and sodium bicarbonate, 63 no benefit. 23 reported an almost complete remission with HYCHSA, 26 slight benefit, 33 no benefit.
Conclusions: Prevalence of BMS in GERD patients was similar to that reported for chronic chough and pharyngitis. Low levels of G17 were found in the majority of BMS patients. Finally, we observed a greater benefit from barrier drugs therapy than from PPI therapy in BMS patients. (www.actabiomedica.it)
Downloads
References
2. Jääskeläinen SK, Woda A. Burning mouth syndrome. Cephalalgia. 2017 Jun;37(7):627-647. doi: 10.1177/0333102417694883.
3. Wu S, Zhang W, Yan J, Noma N, Young A, Yan Z. Worldwide prevalence estimates of burning mouth syndrome: A systematic review and meta-analysis. Oral Dis. 2021 Apr 5. doi: 10.1111/odi.13868.
4. Russo M, Crafa P, Guglielmetti S, Franzoni L, Fiore W, Di Mario F. Burning Mouth Syndrome Etiology: A Narrative Review. J Gastrointestin Liver Dis. 2022 Jun 12;31(2):223-228. doi: 10.15403/jgld-4245.
5. Lechien JR, Hans S, De Marrez LG, et al. Prevalence and Features of Laryngopharyngeal Reflux in Patients with Primary Burning Mouth Syndrome. Laryngoscope. 2021 Oct;131(10):E2627-E2633. doi: 10.1002/lary.29604
6. Di Mario F, Crafa P, Franceschi M, et al. Low Levels of Gastrin 17 are Related with Endoscopic Findings of Esophagitis and Typical Symptoms of GERD. J Gastrointestin Liver Dis. 2021 Feb 12;30(1):25-29. doi: 10.15403/jgld-2952.
7. Di Mario F, Franzoni L, Franceschi M, Rodriguez-Castro KI, Russo M, Crafa P. Low levels of G17 and Barrett esophagus: a clinical relationship. Clin Chem Lab Med. 2022 Apr 28;60(7):e165-e167. doi: 10.1515/cclm-2022-0362.
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.